top of page
Transmutex Logo Dark

We have built an entirely new method of energy production based on thorium, a common metal that is three times more prevalent than uranium worldwide. 


Our systems produce profitable, carbon-free energy via a non-self-sustaining reaction by coupling a particle accelerator to a subcritical fuel assembly. 

  • Writer's pictureFranklin Servan-Schreiber

Collaboration with Institute Hubert Curien

Announcing a collaboration with the famed Institute Hubert Curien located in Strasbourg, France.

Transmutex is honored to announce a collaboration with the famed Institute Hubert Curien (IPHC ) a laboratory co-managed by CNRS and the University of Strasbourg, France.

The collaboration will focus on the study of irradiation in high energy particle accelerators. Transmutex is keenly focused on safety and the entire life cycle of the plants. Learning more about irradiations within high-powered cyclotron will be determinant in the dismantling of the equipment at the end of the life for the plants.

View of Strasbourg, France, one of the most picturesque and dynamic city in Europe.

The work will involve Monte Carlo simulations to be carried out in order to estimate the threshold reaction rates and to trace the induced. Simulation calculations will be compared with experimental measurements by high resolution gamma-ray spectrometry in situ and in the laboratory using an anti-Compton system. The simulation results will also be compared in particular to those obtained by the ActiWiz code developed by CERN to estimate the activation products of the various particle accelerators present on the site. The database generated will make it possible to calculate analytically the impact of materials (compositions, geometries, irradiation times) on the activation of the parts of the future Transmutex cyclotrons.

The project leader for IPHC will be Professor Abdel-Mjid Nourreddine , Professor at the University of Strasbourg and member of the Dosimetry Simulation Instrumentation (DeSIs) team of the Department of Subatomic Research of the IPHC. Within the framework of this contract, Jonathan Collin, will be doing his doctorate on the problem of the activation/dismantling of materials and the radiological inventory in the new cyclotrons developed by Transmutex, and Doctor Giuliana Galli-Carminati will contribute within the framework of achieving her HDR diploma (Habilitation à diriger des recherches, the highest diploma in French Higher Education).

The Cockroft-Walton particle accelerator that operated on the Strasbourg University campus. It was rebuilt and installed in 2000 on the lawn as a memorial for the major role it played in the development of nuclear physics in France. Copyright: Photothèque des laboratoires de l'IN2P3, CNRS

The IPHC is located on the Cronenbourg/Strasbourg University Campus, which offers a state-of-the-art research environment, mainly in the fields of chemistry and physics. It has developed a world-renowned expertise in nuclear instrumentation (semiconductor detectors, scintillators, CMOS, ...), electronics and data acquisition in the field of fundamental and applied physics related to energy, health and the environment. It also develops studies in radiochemistry in the fields of environmental and nuclear power cycle.

The activities of the DeSIs team are located at the intersection between nuclear physics and its societal applications. Its research work focuses on radiation protection issues for health (radiotherapy, medical imaging), the environment (radioactivity) and industry (nuclear energy, industrial irradiation). They are related in particular to the development of new systems for measuring ionizing radiation, combined with the optimization of Monte Carlo simulation codes (Geant4, GATE, MCNP/FISPACT), for dosimetry and characterization of radionuclides in the environment. The team's activities are also part of a policy of openness to society through diversified collaborations with academic, industrial and hospital partners.

Transmutex is deeply grateful to Doctor Yves Schutz for his initiative to bring Transmutex together with the IPHC.

bottom of page